Approximately 50% of patients with light chain amyloidosis have t(11;14), with a consequential overexpression of cyclin D1 and the B-cell lymphoma 2 (BCL-2) protein in plasma cells, allowing them to avoid apoptosis [7]. This evidence concerns the gene BCL2 and AL amyloidosis.